Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
949.2500 13.85 (1.48%)
NSE Dec 04, 2025 15:31 PM
Volume: 2.3M
 

logo
Natco Pharma Ltd.
17 Feb 2017
949.25
1.48%
HDFC Securities
Revenue rose by 54.83% to Rs. 642.86 Cr in Q3FY17 when compared to the previous quarter. Also, it grew by 133.62% when compared with Q3FY16.
Number of MF schemes decreased from 47 to 19 in Sep 2025 qtr
More from Natco Pharma Ltd.
Recommended